Dr. Ryan Edwin Hollingshead, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 208 Fox Hill Rd, Hampton, VA 23669 Phone: 757-850-0500 |
Dr. Kevin James Westby, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 2216 Executive Dr, Suite A, Hampton, VA 23666 Phone: 757-827-3210 Fax: 757-827-9089 |
Angel Jarob Ramirez, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 208 Fox Hill Rd Ste C, Hampton, VA 23669 Phone: 757-850-0500 |
Dr. Hassan Elahi, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 208 Fox Hill Rd, Hampton, VA 23669 Phone: 757-850-0500 |
Dr. Stephen Boronczyk, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 4001 Coliseum Dr Ste 200, Hampton, VA 23666 Phone: 757-827-2220 Fax: 757-865-4193 |
Dr. Kevin Scott Steele, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 183 Woodland Road, Hampton, VA 23663 Phone: 757-723-1899 Fax: 757-723-8669 |
Dr. Jason Michael Abbott, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2021a Cunningham Dr, Suite 3, Hampton, VA 23666 Phone: 757-838-8820 Fax: 757-838-8823 |
Dr. Brian William Scott, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 35 Adriatic Dr, Hampton, VA 23664 Phone: 757-604-8600 |
News Archive
The effectiveness of psychotherapies for social anxiety disorder (SAD) is typically evaluated using self- and clinician-reported symptom change, while biomarkers of treatment response are rarely measured.
In a recent paper published in the prestigious journal Cell, researchers from Sweden and Italy show that inflammatory response in Multisystem Inflammatory Syndrome in Children associated with coronavirus disease (COVID-19) differs from the cytokine storm found in severe acute illness, involving autoantibodies at the same time and sharing several features with Kawasaki disease.
The American College of Physicians (ACP) today sent a letter to House leaders voicing the College's support for key policies in the Affordable Health Care for America Act.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, announced that it has reached the targeted enrollment of 105 evaluable patients in its international Phase 2b clinical trial with aldoxorubicin as a first-line treatment for soft tissue sarcoma.
"A team of international scientists has found that a type of hereditary disorder in some communities in South-East Asia and the South-West Pacific protects its sufferers from malaria, a finding that could drive future vaccine design," SciDev.Net reports.
› Verified 9 days ago